The TCGA data showed that young-age breast cancer patients have a lower level of expression of RANBP3L, GLYATL-1, and ESR1, whereas ACVR2A, SERPINE2, and PCDHGB7 have higher expression in young-age breast cancer patients compared to old age patients. Here, ACVR2A is linked to breast carcinoma.